These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 2700474)

  • 21. beta-adrenoceptor antagonism and intraocular pressure. A clinical study on propranolol, practolol and atenolol.
    Wettrell K
    Acta Ophthalmol Suppl; 1977; (134):1-54. PubMed ID: 22980
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension.
    Orzalesi N; Rossetti L; Invernizzi T; Bottoli A; Autelitano A
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2566-73. PubMed ID: 10937568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the ocular hypotensive effects of bimatoprost and timolol-dorzolamide combination in patients with elevated intraocular pressure: a 6-month study.
    Ozturk F; Ermis SS; Inan UU
    Acta Ophthalmol Scand; 2007 Feb; 85(1):80-3. PubMed ID: 17244215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Glaucoma and ocular hypertension: the importance of intraocular pressure in treatment decisions in France].
    Bron A; Nordmann JP; Baudouin C; Rouland JF; Kadi A; Sartral M
    J Fr Ophtalmol; 2003 Nov; 26(9):895-903. PubMed ID: 14631273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The influence of 0.85% RS-timolol and 0.5% S-timolol on intraocular pressure and systemic arterial blood pressure, heart rate, ECG, expiratory capacity in patients with ocular hypertension and primary open-angle glaucoma].
    Czechowicz-Janicka K; Staszkiewicz J; Strzałkowska M; Krajewska M; Popiołek B; Christman A
    Klin Oczna; 1999; 101(5):333-7. PubMed ID: 10714069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the nocturnal effects of once-daily timolol and latanoprost on intraocular pressure.
    Liu JH; Kripke DF; Weinreb RN
    Am J Ophthalmol; 2004 Sep; 138(3):389-95. PubMed ID: 15364220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraocular pressure response to medication in a clinical setting: the Marshfield Clinic Personalized Medicine Research Project.
    McCarty CA; Mukesh BN; Kitchner TE; Hubbard WC; Wilke RA; Burmester JK; Patchett RB
    J Glaucoma; 2008 Aug; 17(5):372-7. PubMed ID: 18703947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraocular pressure abnormalities associated with central and hemicentral retinal vein occlusion.
    Hayreh SS; Zimmerman MB; Beri M; Podhajsky P
    Ophthalmology; 2004 Jan; 111(1):133-41. PubMed ID: 14711725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized, investigator-masked comparison of diurnal responder rates with bimatoprost and latanoprost in the lowering of intraocular pressure.
    Choplin N; Bernstein P; Batoosingh AL; Whitcup SM;
    Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S19-25. PubMed ID: 15016558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Symmetry of fellow-eye intraocular pressure responses to topical glaucoma medications.
    Realini T; Vickers WR
    Ophthalmology; 2005 Apr; 112(4):599-602. PubMed ID: 15808250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A short term study of the additive effect of timolol and brimonidine on intraocular pressure.
    Arici MK; Sayici M; Toker M; Erdoğan H; Topalkara A
    Eye (Lond); 2002 Jan; 16(1):39-43. PubMed ID: 11913886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of topical atenolol on intraocular pressure.
    Wettrell K; Pandolfi M
    Br J Ophthalmol; 1977 May; 61(5):334-8. PubMed ID: 326301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corn silk aqueous extracts and intraocular pressure of systemic and non-systemic hypertensive subjects.
    George GO; Idu FK
    Clin Exp Optom; 2015 Mar; 98(2):138-49. PubMed ID: 25727941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topical atenolol versus pilocarpine: a double-blind study of the effect on ocular tension.
    Wettrell K; Wilke K; Pandolfi M
    Br J Ophthalmol; 1978 May; 62(5):292-5. PubMed ID: 350263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of atenolol and adrenaline with respect to intraocular pressure.
    Rushton A
    Br J Clin Pharmacol; 1979 Jun; 7(6):575-8. PubMed ID: 465279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Blood Pressure Reduction on Intraocular Pressure and Ophthalmic Artery Blood Flow Velocity in Hypertension.
    Behera G; Nagaraj GA; Thirunavukarasu SC; Jayaraman R; Murugesan R; Subramanian A
    J Ocul Pharmacol Ther; 2022 Mar; 38(2):148-155. PubMed ID: 34964660
    [No Abstract]   [Full Text] [Related]  

  • 37. Atenolol 4% eye drops and glaucoma. A double-blind short-term clinical trial of a new beta1-adrenergic blocking agent.
    Ros FE; Dake CL; Offerhaus L; Greve EL
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1977 Dec; 205(1):61-70. PubMed ID: 341739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of oral ketanserin administration on intraocular pressure in glaucomatous patients.
    Costagliola C; Scibelli G; Fasano ML; Ferrara LA; Mastropasqua L
    Exp Eye Res; 1991 May; 52(5):507-10. PubMed ID: 2065721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atenolol versus adrenaline eye drops and an evaluation of these two combined.
    Phillips CI; Gore SM; Gunn PM
    Br J Ophthalmol; 1978 May; 62(5):296-301. PubMed ID: 350264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early dose response analysis of ocular hypotensive effects of propranolol in patients with ocular hypertension.
    Wettrell K; Pandolfi M
    Br J Ophthalmol; 1976 Oct; 60(10):680-3. PubMed ID: 795456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.